<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03047070</url>
  </required_header>
  <id_info>
    <org_study_id>SM22017</org_study_id>
    <nct_id>NCT03047070</nct_id>
  </id_info>
  <brief_title>Lidocaine in Nasal Sinuscopy</brief_title>
  <official_title>Lidocaine Infusion in Functional Endoscopic Sinus Surgery</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Functional endoscopic sinus surgery (FESS) is a commonly performed procedure. It is known
      that bleeding during FESS can affect directly to the visibility of safe landmarks and
      surgical outcomes.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Functional endoscopic sinus surgery (FESS) is a commonly performed procedure in the head and
      neck field. It is known that bleeding during FESS can affect directly to the visibility of
      safe landmarks and surgical outcomes.

      Use of vasoactive drugs to control bleeding is not without pitfalls. Systemic effects of
      epinephrine may constitute a potential hazard in patients with hypertension, ischemic heart
      disease, anemia, preexistent liver or renal damage and endocrine dysfunction
      (hyperthyroidism, pheochromocytoma and diabetes mellitus).

      Lidocaine is a prototypical local anesthetic, but it also has systemic effects that are
      mediated by inhibitory effects on N-methyl-d-aspartate receptors and leukocyte priming.
      Consequently, systemic lidocaine is antiinflammatory, analgesic, and antihyperalgesic.
      Randomized clinical trials, however, have produced mixed results. Several studies have shown
      reduction in postoperative opioid consumption and pain scores, whereas others have failed to
      show a benefit.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 9, 2017</start_date>
  <completion_date type="Anticipated">June 20, 2018</completion_date>
  <primary_completion_date type="Anticipated">June 20, 2018</primary_completion_date>
  <phase>Phase 2</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>intraoperative bleeding</measure>
    <time_frame>24 hours</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Intraoperative Bleeding</condition>
  <arm_group>
    <arm_group_label>Lidocaine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>IV Lidocaine infusion</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>IV normal saline infusion</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lidocaine</intervention_name>
    <description>IV Lidocaine infusion</description>
    <arm_group_label>Lidocaine</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Normal saline</intervention_name>
    <description>IV normal saline infusion</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients, 20-50 yr ASA class I,II, and III Elective Functional endoscopic sinus
             surgery (FESS).

        Exclusion Criteria:

          -  Allergy to the study medication, pre-existing chronic pain at any site requiring
             treatment, Psychiatric disease, hepatic or renal impairment, seizure disorder
             requiring medication within the previous 2 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>50 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Seham M Moeen</last_name>
    <phone>2413201</phone>
    <phone_ext>088</phone_ext>
    <email>seham.moeen@yahoo.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Faculty of Medicine Assuit University</name>
      <address>
        <city>Asyut</city>
        <state>Assuit</state>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seham Ibrahim, Lecturer</last_name>
      <phone>0882413201</phone>
      <email>seham.moeen@yahoo.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Seham Mohamed Moeen Ibrahim</name>
      <address>
        <city>Asyut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seham M Moeen, MD</last_name>
      <phone>2413201</phone>
      <phone_ext>088</phone_ext>
      <email>seham.moeen@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 6, 2017</study_first_submitted>
  <study_first_submitted_qc>February 6, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 8, 2017</study_first_posted>
  <last_update_submitted>March 8, 2018</last_update_submitted>
  <last_update_submitted_qc>March 8, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 12, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Seham Mohamed Moeen Ibrahim</investigator_full_name>
    <investigator_title>lecturer</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Blood Loss, Surgical</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lidocaine</mesh_term>
  </intervention_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

